{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:55:59Z","timestamp":1791176159891,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2253,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Hepatitis C virus (HCV) infection leads to acute and chronic liver diseases, and new classes of anti-HCV therapeutics are needed. Cyclosporine A (CsA) inhibits HCV replication and CsA derivatives that lack the immunosuppressive function are currently in clinical trials as candidate anti-HCV drugs. Here we characterize several independently derived HCV replicons with varying levels of CsA resistance due to mutations in nonstructural protein 5B (NS5B), the HCV-encoded polymerase. Mutant HCV replicons engineered with these mutations showed resistance to CsA. The mutations reside in two distinct patches in the polymerase: the template channel and one face of a concave surface behind the template channel. Mutant NS5B made by cells expressing the HCV replicon had increased ability to bind to RNA in the presence of CsA. Purified recombinant NS5B proteins containing the mutations were better at <jats:italic toggle=\"yes\">de novo<\/jats:italic> initiated RNA synthesis than the wild-type control. Furthermore, the mutant proteins were able to bind RNA with \u22488-fold higher affinity. Last, mutation near the template channel alleviated the lethal phenotype of a mutation in the concave patch, P540A. This intramolecular compensation for the HCV replicase function by amino acid changes in different domains was further confirmed in an infectious cell culture-derived virus system. <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic> An increased level of CsA resistance is associated with distinct mutations in the NS5B gene that increase RNA binding in the presence of CsA, and the intramolecular communications between residues of the thumb and the C-terminal domains are important for HCV replicase function. (Hepatology 2009.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.22987","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T17:46:58Z","timestamp":1239040018000},"page":"25-33","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A #"],"prefix":"10.1097","volume":"50","author":[{"given":"Zhe","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Robida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreedhar","family":"Chinnaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Robotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather B.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Irsigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng C.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20241201","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/jhep.2003.50449","article-title":"Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.","volume":"38","author":"Watashi","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R2-5-20241201","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2003.11.080","article-title":"Specific inhibition of hepatitis C virus replication by cyclosporin A.","volume":"313","author":"Nakagawa","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R3-5-20241201","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/hep.21587","article-title":"Evaluation of a cyclophilin inhibitor in hepatitis C virusinfected chimeric mice in vivo.","volume":"45","author":"Inoue","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R4-5-20241201","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00535-002-1104-5","article-title":"Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial.","volume":"38","author":"Inoue","year":"2003","journal-title":"J Gastroenterol"},{"key":"R5-5-20241201","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/lt.20532","article-title":"Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.","volume":"12","author":"Firpi","year":"2006","journal-title":"Liver Transpl"},{"key":"R6-5-20241201","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.transproceed.2007.08.086","article-title":"Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.","volume":"39","author":"Guitard","year":"2007","journal-title":"Transplant Proc"},{"key":"R7-5-20241201","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3748\/wjg.v12.i5.697","article-title":"Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis.","volume":"12","author":"Hilgard","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R8-5-20241201","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/lt.20222","article-title":"Impact of tacrolimus versus cyclosporine in hepatitis C virusinfected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.","volume":"10","author":"Martin","year":"2004","journal-title":"Liver Transpl"},{"key":"R9-5-20241201","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.transproceed.2006.10.040","article-title":"A cyclosporinebased immunosuppressive regimen may be better than tacrolimus for longterm liver allograft survival in recipients transplanted for hepatitis C.","volume":"38","author":"Rayhill","year":"2006","journal-title":"Transplant Proc"},{"key":"R10-5-20241201","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.22131","article-title":"The cyclophilin inhibitor Debio025 shows potent antihepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.","volume":"47","author":"Flisiak","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R11-5-20241201","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/j.gastro.2005.06.031","article-title":"Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins.","volume":"129","author":"Nakagawa","year":"2005","journal-title":"Gastroenterology"},{"key":"R12-5-20241201","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/JVI.02614-07","article-title":"Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.","volume":"82","author":"Yang","year":"2008","journal-title":"J Virol"},{"key":"R13-5-20241201","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molcel.2005.05.014","article-title":"Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.","volume":"19","author":"Watashi","year":"2005","journal-title":"Mol Cell"},{"key":"R14-5-20241201","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1128\/JVI.02524-06","article-title":"Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro.","volume":"81","author":"Robida","year":"2007","journal-title":"J Virol"},{"key":"R15-5-20241201","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.21809","article-title":"Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B.","volume":"46","author":"Fernandes","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R16-5-20241201","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0969-2126(00)80031-3","article-title":"Crystal structure of the RNAdependent RNA polymerase of hepatitis C virus.","volume":"7","author":"Ago","year":"1999","journal-title":"Structure"},{"key":"R17-5-20241201","doi-asserted-by":"crossref","first-page":"13034","DOI":"10.1073\/pnas.96.23.13034","article-title":"Crystal structure of the RNAdependent RNA polymerase of hepatitis C virus.","volume":"96","author":"Bressanelli","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-5-20241201","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/13305","article-title":"Crystal structure of the RNAdependent RNA polymerase from hepatitis C virus reveals a fully encircled active site.","volume":"6","author":"Lesburg","year":"1999","journal-title":"Nat Struct Biol"},{"key":"R19-5-20241201","doi-asserted-by":"crossref","first-page":"29765","DOI":"10.1074\/jbc.M505423200","article-title":"Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site.","volume":"280","author":"Di Marco","year":"2005","journal-title":"J Biol Chem"},{"key":"R20-5-20241201","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/JVI.80.3.1181-1190.2006","article-title":"Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluencebased inhibition of HCV RNA and protein expression.","volume":"80","author":"Nelson","year":"2006","journal-title":"J Virol"},{"key":"R21-5-20241201","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro.","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-5-20241201","doi-asserted-by":"crossref","first-page":"20535","DOI":"10.1074\/jbc.M801490200","article-title":"A locking mechanism regulates RNA synthesis and host protein interaction by the hepatitis C virus polymerase.","volume":"283","author":"Chinnaswamy","year":"2008","journal-title":"J Biol Chem"},{"key":"R23-5-20241201","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/JVI.74.4.2017-2022.2000","article-title":"De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase.","volume":"74","author":"Zhong","year":"2000","journal-title":"J Virol"},{"key":"R24-5-20241201","doi-asserted-by":"crossref","first-page":"12513","DOI":"10.1128\/JVI.76.24.12513-12525.2002","article-title":"Mechanism of de novo initiation by the hepatitis C virus RNAdependent RNA polymerase: role of divalent metals.","volume":"76","author":"RanjithKumar","year":"2002","journal-title":"J Virol"},{"key":"R25-5-20241201","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1128\/JVI.76.14.7030-7039.2002","article-title":"Selection of 3template bases and initiating nucleotides by hepatitis C virus NS5B RNAdependent RNA polymerase.","volume":"76","author":"Shim","year":"2002","journal-title":"J Virol"},{"key":"R26-5-20241201","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1073\/pnas.081077198","article-title":"Factors regulating template switch in vitro by viral RNAdependent RNA polymerases: implications for RNARNA recombination.","volume":"98","author":"Kim","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-5-20241201","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability.","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat Protoc"},{"key":"R28-5-20241201","doi-asserted-by":"crossref","first-page":"11121","DOI":"10.1128\/JVI.74.23.11121-11128.2000","article-title":"Template requirements for RNA synthesis by a recombinant hepatitis C virus RNAdependent RNA polymerase.","volume":"74","author":"Kao","year":"2000","journal-title":"J Virol"},{"key":"R29-5-20241201","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/75202","article-title":"RNA motifs that determine specificity between a viral replicase and its promoter.","volume":"7","author":"Kim","year":"2000","journal-title":"Nat Struct Biol"},{"key":"R30-5-20241201","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1038\/nprot.2006.395","article-title":"Cell culture and infection system for hepatitis C virus.","volume":"1","author":"Kato","year":"2006","journal-title":"Nat Protoc"},{"key":"R31-5-20241201","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1107\/S0907444900010702","article-title":"Crystallization and preliminary Xray crystallographic studies on the bacteriophage phi6 RNAdependent RNA polymerase.","volume":"56","author":"Butcher","year":"2000","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"R32-5-20241201","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1074\/jbc.M111392200","article-title":"Hepatitis C virus (HCV) NS5A binds RNAdependent RNA polymerase (RdRP) NS5B and modulates RNAdependent RNA polymerase activity.","volume":"277","author":"Shirota","year":"2002","journal-title":"J Biol Chem"},{"key":"R33-5-20241201","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1128\/JVI.77.9.5401-5414.2003","article-title":"Proteinprotein interactions between hepatitis C virus nonstructural proteins.","volume":"77","author":"Dimitrova","year":"2003","journal-title":"J Virol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22987","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200907000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:45:04Z","timestamp":1733060704000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200907000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22987","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}